You are here: Welcome » University of Alberta

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Both sides next revision
university_of_alberta [2022/10/26 22:23]
liam [COVID-19]
university_of_alberta [2022/10/26 22:55] (current)
liam [Metabolic and Cardiovascular Diseases Laboratory]
Line 12: Line 12:
  
 In March 2022, the University announced the creation of the Pfizer Applied Clinical Pharmacology Program under the Faculty of Pharmacy and Pharmaceutical Sciences. The new program is in partnership with [[pharmaceutical_companies:Pfizer]] and [[Applied Pharmaceutical Innovation]] (API).((//Pfizer, Applied Pharmaceutical Innovation and University of Alberta launch the Pfizer Applied Clinical Pharmacology Program.// (2022, March 16). Applied Pharmaceutical Innovation. https://web.archive.org/web/20221026202112/https://appliedpharma.ca/pfizer-applied-pharmaceutical-innovation-and-university-of-alberta-launch-the-pfizer-applied-clinical-pharmacology-program/)) In March 2022, the University announced the creation of the Pfizer Applied Clinical Pharmacology Program under the Faculty of Pharmacy and Pharmaceutical Sciences. The new program is in partnership with [[pharmaceutical_companies:Pfizer]] and [[Applied Pharmaceutical Innovation]] (API).((//Pfizer, Applied Pharmaceutical Innovation and University of Alberta launch the Pfizer Applied Clinical Pharmacology Program.// (2022, March 16). Applied Pharmaceutical Innovation. https://web.archive.org/web/20221026202112/https://appliedpharma.ca/pfizer-applied-pharmaceutical-innovation-and-university-of-alberta-launch-the-pfizer-applied-clinical-pharmacology-program/))
 +
 +===== Organization =====
 +
 +==== Metabolic and Cardiovascular Diseases Laboratory ====
 +
 +U of A's MCDL has previously received research funding from:((//Previous Funding Partners.// Metabolic and Cardiovascular Diseases Laboratory. Retrieved October 26, 2022, from https://web.archive.org/web/20221026204817/https://mcvd.ualberta.ca/research/previous-funding-partners/))
 +
 +<WRAP column col4>
 +  * [[Advanced Foods and Materials Network]] (AFMNet)
 +  * [[Alberta Advanced Education and Technology]]
 +  * [[Alberta Diabetes Institute]] (ADI)
 +  * [[Alberta Health Services]] (AHS)
 +  * [[Alberta Innovates]]
 +  * [[Alberta Livestock and Meat Agency]] (ALMA)
 +  * [[American Society of Parenteral & Enteral Nutrition]]
 +  * [[Beef Information Centre]] (BIC)
 +  * [[Canada Foundation for Innovation]] (CFI)
 +  * [[Canadian Institutes of Health Research]] (CIHR)
 +  * [[Canadian Lipoprotein Conference]]
 +  * [[Ceapro]]
 +  * [[Dairy Farmers of Canada]]
 +  * [[Heart and Stroke Foundation of Canada]]
 +  * [[International Atherosclerosis Society]]
 +  * [[International Life Sciences Institute]]
 +  * [[pharmaceutical_companies:Johnson & Johnson]]
 +  * [[Mazankowski Alberta Hearth Institute]]
 +  * [[pharmaceutical_companies:Merck]]
 +  * [[MITACS]]
 +  * [[National Research Council Canada]] (NRC)
 +  * [[Natural Sciences and Engineering Research Council]] (NSERC)
 +  * [[Networks of Centres of Excellence of Canada]]
 +  * [[pharmaceutical_companies:Pfizer]]
 +  * [[pharmaceutical_companies:Sanofi-Aventis]]
 +  * [[Spanish Ministry of Science and Innovation]]
 +  * [[Stollery Children's Hospital Foundation]]
 +  * [[TEC Edmonton]]
 +  * [[University Hospital Foundation]]
 +  * [[Women's & Children's Health Research Institute]]
 +</WRAP>
Back to top